Global Brain Health Clinical Exchange Platform - Virtual Workshop

26 Apr 2024


The next Clinical Exchange workshop for 2024 will run on 26 April, 2pm (GMT):

From research to policy: advocating for Brain Health

The time to address the global burden of neurological diseases is now. With ample data and the landmark WHO's Intersectoral Global Action Plan, engaging policymakers is imperative. But how do we translate evidence into policy? Skillful advocacy is the key. Join our expert panel to discuss essential ways in which doctors, researchers and members of the public can use advocacy to contribute to global action on neurological diseases.

Chair: Prof. Mayowa OWOLABI, MBBS, MSc, DrM, MD, DSc, FRCP, FAAN, FAS
Professor of Neurology | Director of the Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Nigeria | Regional Vice President World Federation for NeuroRehabilitation

Professor Owolabi’s expertise spans neurology, brain health and global health as well as implementation science, translational community-based genomic epidemiology of non-communicable diseases, and the study of hypertension, stroke, and cardiovascular diseases. He is Principal Investigator on a number of groundbreaking initiatives such as: African Rigorous Innovative Stroke Epidemiological Surveillance (ARISES), Stroke Investigative Research and Educational Network (SIREN) - the largest study of stroke on the African continent, and the Systemic Investigation of Blacks with Stroke using genomics (SIBS-Genomics), which focus on stroke epidemiology and genetics. He is the pioneer Regional Vice-President (Africa), and member of the Presidium, World Federation of Neurorehabilitation (Africa); member Board of Directors, World Stroke Organization; African Regional Director, World Hypertension League; Lead Co-Chair, WSO- Lancet Commission on stroke; and Member/Rapporteur of the WHO Technical Action Group on NCD (Research and Innovation).


Dr Justin Jordan, MD, MPH, FAAN | Associate Professor of Neurology, Harvard Medical

Dr Jordan's clinical interests are in primary nervous system tumors, neurofibromatosis type 1, and schwannomatosis.  His research interests are in the identification and targeted treatment of molecular drivers of tumor formation. He is a leader in defining and measuring quality care across multiple diseases in the neuro-oncology space. Dr. Jordan is passionate about the intersection of health policy and the practice of medicine; he chairs the Board of Heath in his local government, runs the Center for Health Policy and Advocacy within the Department of Neurology at Massachusetts General Hospital, serves as Vice Chair of the American Academy of Neurology (AAN)’s Health Policy Subcommittee, as a member of the AAN’s Brain Health Committee, and as a member of the organizing team for the AAN’s Brain Health Summit in 2022 and 2023. Finally, Dr. Jordan is a steadfast advocate for health policy improvement, leading the AAN’s Palatucci Advocacy Leadership Forum in 2023, and currently serving on the board of directors for two large disease-specific advocacy organizations.

Mr Sam Mountney | Policy and External Affairs Manager, Neurological Alliance

The Neurological Alliance is England’s largest coalition of over 90 neurological advocacy organizations. Sam led the delivery of My Neuro Survey, the largest national neurological patient experience survey in the UK. He was previously seconded to National Voices, the leading coalition of health and care charities, as Head of Policy and spent three and a half years at Epilepsy Action heading up their health policy and campaigning efforts. Prior to joining the third sector, Sam worked for a Member of Parliament managing their Westminster office after completing an MA at the University of Leeds and a BSc at the University of Birmingham.

Web link:

Direct registration link: